US Stock MarketDetailed Quotes

CLRB Cellectar BioSciences

Watchlist
  • 0.2350
  • -0.0030-1.26%
Close Dec 20 16:00 ET
  • 0.2380
  • +0.0030+1.28%
Post 19:59 ET
9.70MMarket Cap-0.17P/E (TTM)

Cellectar BioSciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cellectar BioSciences Q3 2024 Earnings Date

Currency：USDNov 18, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
0
0
0
--
--
--
EPS
-0.37
-0.40
-0.03
Miss Est.
+69.15%
+74.19%
-7.18%
Analyst Rating
Buy

Dec 22, 2024

Cellectar BioSciences Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
Nov 18, 20242024/Q30.000 / 0.000--
Aug 13, 20242024/Q20.000 / 0.000--
May 14, 20242024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
Nov 18, 20242024/Q30.000 / 0.000--
Aug 13, 20242024/Q20.000 / 0.000--
May 14, 20242024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Cellectar BioSciences Earnings Reports

  • Cellectar BioSciences | 10-Q: Q3 2024 Earnings Report

    Nov 18 06:48 ET

  • Cellectar BioSciences | 10-Q: Q2 2024 Earnings Report

    Oct 29 17:15 ET

  • Cellectar BioSciences | 10-Q/A: Quarterly report (Amendment)

    Oct 29 17:09 ET

  • Cellectar BioSciences | 10-K/A: Annual report (Amendment)

    Oct 29 16:59 ET

    • Read more

    Trending US Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Ermenegildo Zegna NV
    ZGN
    +6.16%
    DexCom
    DXCM
    +5.57%
    New Fortress Energy
    NFE
    +5.37%
    Workday
    WDAY
    +2.33%
    eBay
    EBAY
    +1.66%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Dec 22, 2024

    Buy

    • Buy

      66.67%

    • Hold

      33.33%

    • Sell

      0.00%

    Price Target

    No Data